Related Experiment Video

Updated: Jul 10, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

Potential of nanocarrier-mediated delivery of vancomycin for MRSA infections

Vincent O Nyandoro1,2, Eman A Ismail1,3, Abdelrahman Tageldin1

  • 1Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Expert Opinion on Drug Delivery
|February 14, 2025
PubMed
Abstract

Insights

Nanocarriers enhance vancomycin delivery to fight Methicillin-resistant Staphylococcus aureus (MRSA) infections. This approach improves efficacy, reduces toxicity, and aids in overcoming antibiotic resistance.

Area of Science:

  • Nanomedicine
  • Pharmacology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a global health threat due to vancomycin resistance.
  • Vancomycin, the standard treatment, has limitations like nephrotoxicity and poor intracellular penetration.
  • Nanocarrier-mediated delivery presents an innovative strategy to overcome these vancomycin limitations.

Purpose of the Study:

  • To explore the potential of nanocarriers for vancomycin delivery against MRSA.
  • To review how nanocarriers can reduce systemic toxicity and enhance anti-MRSA activity.
  • To examine the role of modeling and simulation in understanding vancomycin-nanocarrier interactions.

Main Methods:

  • Literature review of experimental articles published between 2017 and 2024.
  • Searches conducted in major scientific databases: Web of Science, Google Scholar, PubMed, and Scopus.
  • Analysis of studies focusing on nanocarrier systems for vancomycin delivery and MRSA treatment.

Main Results:

  • Nanocarriers can act as effective delivery systems for vancomycin, potentially offering synergistic antibacterial effects.
  • Sustained release and targeted delivery by nanocarriers can achieve higher therapeutic concentrations at infection sites.
  • Reduced vancomycin doses via nanocarriers minimize systemic toxicity and improve patient outcomes.
  • Simulation techniques offer insights into vancomycin-nanocarrier interactions, aiding in nanosystem optimization.

Conclusions:

  • Nanocarrier-mediated vancomycin delivery shows significant promise for combating MRSA infections.
  • This approach can enhance therapeutic efficacy and mitigate vancomycin's adverse effects.
  • Further research and optimization are crucial for advancing these nanoformulations towards clinical application.
Keywords:
MRSA infectionsNanocarrier-mediatedmethicillin-resistant Staphylococcus aureusnanosized drug delivery systemsnanotechnologyvancomycin

More Related Videos

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

2.9K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

1.4K

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...